ArticleBMC psychiatry2025
Overweight and POMC methylation: epigenetic associations with adolescent depression.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionTo evaluate whether BMI status influences POMC methylation levels and subsequently affects the course of adolescent depression. This study examined the relationship between the methylation levels of different CpG sites in the POMC gene and clinical symptoms across various BMI categories in adolescent depression.
methodsA total of 108 adolescent patients with depressive disorders including 68 with unipolar depression and 40 with bipolar depression participated in the study. They were divided into three groups: 11 underweight individuals (BMI below the age-specific threshold), 75 normal-weight individuals (BMI within the defined normal range), and 22 overweight individuals (BMI between the overweight threshold and obesity threshold). Pyrosequencing methylation analysis was used to assess POMC gene promoter methylation levels
resultsAdolescents in the overweight group exhibited significantly lower methylation levels at CpG6 and CpG8 of the POMC gene compared to their normal-weight and underweight peers. Furthermore, methylation at these sites was associated with clinical and psychological indicators such as Childhood Trauma Questionnaire (CTQ) and Montgomery–Asberg Depression Rating Scale (MADRS) scores. After adjusted for medication use, multivariate linear regression analysis revealed a negative correlation between CpG6 methylation levels and CTQ scores in overweight group.
conclusionThis study shows the association between POMC methylation levels and depressive symptoms in adolescents across different BMI categories. The findings suggest a potential interaction between epigenetic mechanisms, depression and overweight providing a foundation for further mechanistic investigations.
trial registrationNot applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.